Allianz Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.21M Buy
105,973
+83,831
+379% +$7.35M 0.01% 1081
2026
Q1
$2M Sell
22,142
-1,901
-8% -$174K ﹤0.01% 1555
2025
Q4
$2.16M Buy
24,043
+711
+3% +$67.4K ﹤0.01% 1516
2025
Q3
$2.3M Buy
23,332
+691
+3% +$68.5K ﹤0.01% 1438
2025
Q2
$2.07M Sell
22,641
-32,013
-59% -$3.1M ﹤0.01% 1465
2025
Q1
$6.19M Sell
54,654
-18,906
-26% -$2.02M 0.01% 999
2024
Q4
$7.77M Sell
73,560
-21,486
-23% -$2.31M 0.01% 842
2024
Q3
$10.3M Sell
95,046
-25,424
-21% -$2.77M 0.01% 733
2024
Q2
$13.1M Buy
120,470
+17,920
+17% +$2.11M 0.02% 625
2024
Q1
$13.5M Sell
102,550
-16,694
-14% -$2.09M 0.02% 579
2023
Q4
$14.5M Buy
119,244
+24,828
+26% +$2.77M 0.02% 568
2023
Q3
$10.6M Buy
94,416
+17,532
+23% +$2.23M 0.02% 706
2023
Q2
$11.2M Buy
76,884
+25,627
+50% +$3.48M 0.02% 613
2023
Q1
$6.62M Sell
51,257
-12,123
-19% -$1.52M 0.01% 858
2022
Q4
$8.08M Buy
63,380
+14,162
+29% +$1.64M 0.02% 752
2022
Q3
$5.15M Buy
49,218
+905
+2% +$99.3K 0.01% 878
2022
Q2
$5.08M Buy
48,313
+6,497
+16% +$771K ﹤0.01% 1092
2022
Q1
$5.35M Buy
41,816
+3,096
+8% +$373K ﹤0.01% 1196
2021
Q4
$4.78M Sell
38,720
-8,081
-17% -$1.06M ﹤0.01% 1256
2021
Q3
$6.65M Sell
46,801
-18,342
-28% -$2.7M 0.01% 1167
2021
Q2
$10.2M Sell
65,143
-36,387
-36% -$5.89M 0.01% 854
2021
Q1
$15.8M Sell
101,530
-78,395
-44% -$12.1M 0.02% 687
2020
Q4
$26.9M Buy
179,925
+72,875
+68% +$10.3M 0.03% 527
2020
Q3
$14.1M Sell
107,050
-11,996
-10% -$1.57M 0.02% 671
2020
Q2
$13.8M Sell
119,046
-23,230
-16% -$2.68M 0.02% 769
2020
Q1
$14M Buy
142,276
+77,314
+119% +$10.1M 0.02% 700
2019
Q4
$9.44M Buy
64,962
+13,618
+27% +$1.88M 0.01% 1180
2019
Q3
$6.84M Buy
51,344
+6,047
+13% +$781K 0.01% 1294
2019
Q2
$5.18M Buy
45,297
+6,603
+17% +$773K ﹤0.01% 1489
2019
Q1
$4.8M Buy
38,694
+15,291
+65% +$1.74M ﹤0.01% 1481
2018
Q4
$2.36M Buy
23,403
+20,344
+665% +$2.29M ﹤0.01% 1704
2018
Q3
$390K Sell
3,059
-40,633
-93% -$4.83M ﹤0.01% 2431
2018
Q2
$4.73M Sell
43,692
-71,952
-62% -$7.83M ﹤0.01% 1551
2018
Q1
$12.2M Sell
115,644
-72,322
-38% -$8.4M 0.01% 1156
2017
Q4
$22M Sell
187,966
-55,867
-23% -$6.32M 0.02% 933
2017
Q3
$27.7M Buy
243,833
+96,677
+66% +$11.2M 0.02% 817
2017
Q2
$18.3M Sell
147,156
-57,083
-28% -$6.77M 0.02% 1016
2017
Q1
$24.2M Buy
204,239
+14,687
+8% +$1.66M 0.02% 905
2016
Q4
$19M Sell
189,552
-13,391
-7% -$1.44M 0.02% 1033
2016
Q3
$25.6M Buy
202,943
+49,257
+32% +$6.09M 0.02% 825
2016
Q2
$18M Buy
153,686
+21,238
+16% +$2.4M 0.02% 960
2016
Q1
$13.7M Buy
132,448
+29,772
+29% +$2.88M 0.02% 977
2015
Q4
$10.2M Sell
102,676
-3,905
-4% -$382K 0.01% 1044
2015
Q3
$9.72M Sell
106,581
-51,527
-33% -$5.17M 0.01% 1005
2015
Q2
$16.8M Buy
158,108
+1,124
+0.7% +$124K 0.02% 872
2015
Q1
$17.9M Sell
156,984
-35,796
-19% -$4.08M 0.02% 733
2014
Q4
$21.2M Sell
192,780
-22,040
-10% -$2.32M 0.02% 680
2014
Q3
$21M Sell
214,820
-178,847
-45% -$17.6M 0.03% 619
2014
Q2
$39.7M Sell
393,667
-43,890
-10% -$4.28M 0.05% 394
2014
Q1
$40.2M Sell
437,557
-6,856
-2% -$632K 0.05% 387
2013
Q4
$40.2M Sell
444,413
-220,090
-33% -$19M 0.05% 385
2013
Q3
$53M Buy
664,503
+2,947
+0.4% +$232K 0.07% 332
2013
Q2
$48.1M Buy
+661,556
New +$49.5M 0.07% 315

Other funds holding ZBH

Allianz Asset Management's ZBH Position: Q2 2026 in Review

Allianz Asset Management increased its Zimmer Biomet (ZBH) stake by 379% in Q2 2026, buying an estimated $7.35M and bringing the position to 105,973 shares worth $9.21M. The position accounts for 0.01% of the portfolio, ranked #1081.

Allianz Asset Management first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $53M in Q3 2013. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Allianz Asset Management held 105,973 shares of Zimmer Biomet worth $9.21M as of Q2 2026.
  • Allianz Asset Management bought 83,831 Zimmer Biomet shares in Q2 2026, an estimated $7.35M.
  • Zimmer Biomet made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1081 holding.
  • Allianz Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Allianz Asset Management's Zimmer Biomet position peaked at $53M in Q3 2013.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.